Navigation Links
B. Melina Cimler, PhD, Former Senior Vice President of Regulatory & Quality at Adaptive Biotechnologies, Joins NDA Partners
Date:9/27/2018

NDA Partners Chairman Carl Peck, MD, announced today that Dr. B. Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more than 28 years of experience in the life science and FDA-regulated global diagnostic industry has joined the firm as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality systems, clinical affairs, research, and product development organizations with a focus on precision medicine.

Prior to joining NDA Partners, Dr. Cimler served as Senior Vice President of Regulatory and Quality at Adaptive Biotechnologies. She was formerly Head of Global Quality and Vice President of Quality, Regulatory, Clinical, and Government Affairs at Illumina Inc., where she defined and executed the regulatory strategy for the first next generation sequencing platform (MiSeqDx) to receive FDA marketing authorization.

Dr. Cimler has also previously held executive leadership positions in quality management, regulatory affairs, clinical development, and government affairs at Abbott Molecular, Beckman Coulter Inc., Gen-Probe Inc., and CR Bard, Inc., and she was formerly head of Product Development at Epitope, Inc. (now OraSure Technologies, Inc.).

According to Dr. David Feigal, NDA Partners’ Medical Device Practice Manager, “Dr. Cimler’s expertise in regulatory strategies, quality management, clinical affairs, and product development, focus on precision medicine, and experience in the global in vitro diagnostic industry makes her a welcome addition to our team of Expert Consultants. We are very pleased that she has joined NDA Partners.”

Dr. Cimler earned her doctoral degree in pharmacology and her bachelor’s degrees in biology and chemistry from the University of Washington. She currently serves on the Board of Directors of Nanostics, Inc. and is a Scientific Board member of M3 Biotechnology.

About NDA Partners
NDA Partners is a life sciences management consulting firm focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners.com

Read the full story at https://www.prweb.com/releases/b_melina_cimler_phd_former_senior_vice_president_of_regulatory_quality_at_adaptive_biotechnologies_joins_nda_partners/prweb15750970.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, Former Head of Roche Molecular Diagnostics
2. John W. Sheets Jr., Former FDA Director Of The Office Of Device Evaluation, Joins NDA Partners As Expert Consultant
3. Former VP of Clinical Pharmacology at Nektar Therapeutics, Michael A. Eldon, PhD, FCP, Joins NDA Partners as Expert Consultant
4. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
5. Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
6. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
7. Former FDA Official to Conduct Popular ComplianceOnline Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
8. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
9. Former Director of FDA Division of Biostatistics, Gregory Campbell, PhD, joins NDA Partners as Expert Consultant
10. Vinod Shah, PhD, Former Senior Research Scientist in FDA Office of Pharmaceutical Sciences, Joins NDA Partners as Expert Consultant
11. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... March 19, 2019 , ... Konica Minolta ... announced the formation of their inaugural Scientific Advisory Board. , Founded ... takes into account individual variability in genes, environment, and lifestyle to more accurately ...
(Date:3/19/2019)... ... 19, 2019 , ... Cirrascale Cloud Services ®, a ... offering NVIDIA® DGX-1™ deep learning systems as part of its dedicated, multi-GPU deep ... performance for artificial intelligence and deep learning research and development. , “Our customers ...
(Date:3/14/2019)... CITY (PRWEB) , ... March 14, 2019 , ... ... International for their facility in Oklahoma City, OK. EyeCRO joins the Department of ... of Oklahoma Health Sciences Center as the fifth institution in Oklahoma to receive ...
(Date:3/14/2019)... ... 14, 2019 , ... ON NOVEMBER 27, 2018, Nova Oculus ... Machine Canada Inc., had been given approval to begin a clinical patient trial ... (AMD). , The previous month, the medical devices bureau of Health Canada had ...
Breaking Biology Technology:
(Date:3/25/2019)... ... March 25, 2019 , ... Ambry Genetics ... genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., ... Through this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to ...
(Date:3/23/2019)... ... March 21, 2019 , ... Artificial Intelligence (AI) is an ... on machine learning. Machine learning is a branch of AI focused on identifying ... Through machine learning, scientists are able to build predictive models and understand key ...
(Date:3/18/2019)... ... March 18, 2019 , ... Periodontal disease, where bacterial infection of the gums ... the US population. Making this disease particularly challenging to treat is the fact ... are enmeshed in a sticky extracellular material that makes them more resistant to antibiotic ...
Breaking Biology News(10 mins):